Allurion Technologies Inc
Company Profile
Business description
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world’s first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Contact
11 Huron Drive
NatickMA01760
USAT: +1 508 647-4000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
137
Stocks News & Analysis
stocks
AI stocks post big gains in Q3. These are the winners and losers
stocks
12 picks for an income portfolio - Q3 2025 update
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,253.60 | 25.70 | -0.28% |
CAC 40 | 7,975.77 | 3.99 | 0.05% |
DAX 40 | 24,384.03 | 5.74 | 0.02% |
Dow JONES (US) | 46,609.81 | 85.16 | -0.18% |
FTSE 100 | 9,477.30 | 1.84 | -0.02% |
HKSE | 26,957.77 | 183.15 | -0.67% |
NASDAQ | 22,807.80 | 133.87 | -0.58% |
Nikkei 225 | 47,950.88 | 6.12 | 0.01% |
NZX 50 Index | 13,531.29 | 42.05 | 0.31% |
S&P 500 | 6,715.43 | 24.85 | -0.37% |
S&P/ASX 200 | 8,956.80 | 19.10 | -0.21% |
SSE Composite Index | 3,882.78 | 20.25 | 0.52% |